In summary, we have demonstrated that the combination of transient lymphopenia, abnormal Fas-signaling, and antigen exposure leads to the development of a prolonged airway inflammatory phase in our mouse model of experimental asthma. The gene discussed is FAS; the disease is lymphopenia.